A Prospective Randomized Controlled Trial to Evaluate the Effectiveness of the Two Different Appliances in the Treatment of Class II Division 1 Malocclusion

NCT ID: NCT00957489

Last Updated: 2023-05-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

64 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-01-31

Study Completion Date

2008-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Twin-Block treatment and Dynamax treatment for Class II division 1 malocclusion do not have different effects with regards to treatment duration, the quality of dento-occlusal outcome, skeletal and soft tissue profile, patient discomfort and gingival health.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The Dynamax appliance is a relatively new appliance for the treatment of Class II malocclusion and was introduced in 2003. The appliance has the theoretical advantages of incremental mandibular advancement without the need for bite registration, and the ability for the operator to simultaneously provide the functional and fixed appliance phases of treatment. Furthermore, the Dynamax appliance is designed to limit lower both lower incisor proclination and upper incisor retroclination without an increase in lower facial height. There has been limited research into this appliance and only one trial has been carried out. In this study the effects of the Dynamax were compared with the Twin-block, unfortunately, the trial was not carried out to contemporary standards and suffered from severe shortcomings. For example, the non compliance rate was not accounted for in the sample size calculation, the randomisation sequence was not clear, the investigators did not carry out an intention-to-treat analysis, the statistical analysis was simplistic and the study was carried out in a single dental school setting. This raises the question about the efficiency of the Dynamax appliance and whether or not they are effective in a 'real' world setting.

The aim of this study is to compare the effectiveness of the Dynamax appliance and the Twin-block appliance for the treatment of Class II Division 1 malocclusion.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Class II Division 1 Malocclusion

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Functional appliance-Dynamax

Group Type EXPERIMENTAL

Dynamax appliance

Intervention Type OTHER

Functional appliance- twin block

Conventional treatment

Group Type OTHER

Twin-block appliance

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dynamax appliance

Intervention Type OTHER

Twin-block appliance

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with a Class II malocclusion as defined by British Standards Institute classification.
* Overjet greater than 6mm
* Aged 10-14 years
* Clinical examination indicates a functional appliance is not contraindicated

Exclusion Criteria

* Orthognathic treatment is required or there is a strong indication it will be required in the future
* Possession of a craniofacial anomaly
* Previous orthodontic treatment and/or premolar extraction
* Hypodontia of more than one teeth in any quadrant excluding third molars
* Inadequate oral hygiene
Minimum Eligible Age

10 Years

Maximum Eligible Age

14 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Health Service, United Kingdom

OTHER_GOV

Sponsor Role collaborator

University of Manchester

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Badri Thiruvenkatachari

Dr

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kevin O'Brien, BDS, MSc, FDSRCS, DORth, PhD

Role: PRINCIPAL_INVESTIGATOR

Prof of Orthodontics/ Associate Dean Teaching and Learning, University of Manchester

Jonathan Sandler, BDS, MSc, FDSRCS, MOrth RCS

Role: PRINCIPAL_INVESTIGATOR

Consultant Orthodontist, Chesterfield NHS Trust

Alison Murray, BDS, MSc, FDSRCS, MORth RCS

Role: PRINCIPAL_INVESTIGATOR

Consultant Orthodontist, Derby NHS Trust

Badri ' Thiruvenkatachari, BDS, MDS, MOrth RCS, PhD

Role: STUDY_DIRECTOR

Clinical Teaching Fellow in Orthodontics, University of Manchester

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Chesterfield Royal Hospital

Chesterfield, , United Kingdom

Site Status

Derby Royak Hospital NHS Trust

Derby, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DTT project

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.